AIM
ARK Investment Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-775,787
| Closed | -$5.46M | – | 228 |
|
|
2023
Q2 | $5.46M | Sell |
775,787
-33,179
| -4% | -$234K | 0.04% | 123 |
|
|
2023
Q1 | $4.94M | Sell |
808,966
-10,898
| -1% | -$66.6K | 0.03% | 124 |
|
|
2022
Q4 | $5.24M | Sell |
819,864
-1,497,353
| -65% | -$9.57M | 0.05% | 124 |
|
|
2022
Q3 | $22.2M | Sell |
2,317,217
-618,462
| -21% | -$5.92M | 0.15% | 80 |
|
|
2022
Q2 | $19.8M | Sell |
2,935,679
-101,764
| -3% | -$687K | 0.12% | 92 |
|
|
2022
Q1 | $50.6M | Sell |
3,037,443
-4,164,075
| -58% | -$69.3M | 0.21% | 69 |
|
|
2021
Q4 | $137M | Sell |
7,201,518
-4,448,319
| -38% | -$84.9M | 0.42% | 46 |
|
|
2021
Q3 | $287M | Sell |
11,649,837
-6,800,876
| -37% | -$168M | 0.69% | 36 |
|
|
2021
Q2 | $480M | Sell |
18,450,713
-1,275,937
| -6% | -$33.2M | 0.89% | 30 |
|
|
2021
Q1 | $625M | Buy |
19,726,650
+4,428,828
| +29% | +$140M | 1.24% | 23 |
|
|
2020
Q4 | $710M | Buy |
15,297,822
+7,394,514
| +94% | +$343M | 1.89% | 13 |
|
|
2020
Q3 | $260M | Buy |
7,903,308
+3,668,035
| +87% | +$121M | 1.54% | 19 |
|
|
2020
Q2 | $116M | Buy |
4,235,273
+3,348,094
| +377% | +$91.9M | 1.25% | 24 |
|
|
2020
Q1 | $26.6M | Buy |
887,179
+63,835
| +8% | +$1.91M | 0.66% | 33 |
|
|
2019
Q4 | $22.8M | Buy |
823,344
+8,548
| +1% | +$237K | 0.57% | 38 |
|
|
2019
Q3 | $14.8M | Buy |
814,796
+7,108
| +0.9% | +$129K | 0.32% | 50 |
|
|
2019
Q2 | $19.8M | Buy |
807,688
+116,194
| +17% | +$2.85M | 0.5% | 40 |
|
|
2019
Q1 | $6.58M | Sell |
691,494
-34,866
| -5% | -$332K | 0.19% | 60 |
|
|
2018
Q4 | $6.43M | Buy |
726,360
+301,540
| +71% | +$2.67M | 0.26% | 53 |
|
|
2018
Q3 | $4.78M | Buy |
424,820
+302,197
| +246% | +$3.4M | 0.14% | 70 |
|
|
2018
Q2 | $1.57M | Buy |
122,623
+57,527
| +88% | +$737K | 0.06% | 95 |
|
|
2018
Q1 | $1.1M | Buy |
+65,096
| New | +$1.1M | 0.05% | 100 |
|